8-K: Astrana Health Finalizes $674.9M Acquisition, Boosts Pro Forma Revenue
Acquisition Update
Astrana Health, Inc. has completed its $674.9 million acquisition of Prospect Health Plan and Alta Newport Hospital, significantly increasing its pro forma annual revenue to over $3.8 billion.
Summary
- Astrana Health, Inc. completed the acquisition of Prospect Health Plan, Inc., Alta Newport Hospital, LLC, and substantially all assets of certain PHP Holdings, LLC subsidiaries on July 1, 2025.
- The total purchase consideration for the acquisition was approximately $674.9 million in cash.
- Astrana financed the acquisition by borrowing $707.3 million from a five-year delayed draw term loan credit facility.
- Pro forma combined total revenue for the year ended December 31, 2025, is estimated at $3,819,909,000, up from Astrana's historical $3,181,769,000.
- Pro forma net income attributable to Astrana Health, Inc. for the year ended December 31, 2025, is estimated at $41,391,000, resulting in basic and diluted earnings per share of $0.84.
- The acquired business (PHP Holdings, LLC & Rhode Island Market) reported a net loss of $38,690,000 for the nine months ended June 30, 2025, a slight improvement from a $43,709,000 net loss in the prior year period.
- The acquired business's operating income significantly decreased to $48,476,000 for the nine months ended June 30, 2025, from $88,389,000 in the prior year.
- The acquired business's total liabilities increased to $1,569,938,000 as of June 30, 2025, from $1,488,899,000 as of September 30, 2024, with a substantial increase in the current portion of long-term debt.
- All outstanding debt obligations of the acquired business under the PhysicianCo Loan Agreement were repaid in full with proceeds from the Astrana sale on July 1, 2025.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a strategically positive move for Astrana Health, significantly expanding its revenue base and market presence, despite the acquired entity's historical financial challenges and regulatory non-compliance which Astrana will now need to manage.
Positives
- The acquisition significantly expands Astrana Health's revenue base, with pro forma total revenue projected to reach over $3.8 billion for the year ended December 31, 2025.
- The acquired business's net loss slightly improved to $38.69 million for the nine months ended June 30, 2025, compared to $43.71 million for the same period in 2024.
- The acquired business successfully released a full valuation allowance of $41,754,000 on deferred tax assets as of June 30, 2025, indicating management's belief in future taxable income.
- All significant debt obligations of the acquired business, including the PhysicianCo Term Loan, Bridge Loan, and Amendment No. 6 Incremental Term Loan, totaling over $1.2 billion, were fully repaid upon the closing of the acquisition.
- MPT released all rights, interests, and liens on the equity and assets sold to Astrana, including the termination of the Foothill Mortgage Loan.
Negatives
- The acquired business (PHP Holdings, LLC & Rhode Island Market) experienced a significant decrease in operating income, falling to $48,476,000 for the nine months ended June 30, 2025, from $88,389,000 in the prior year period.
- The acquired business's interest expense, net, increased substantially to $121,832,000 for the nine months ended June 30, 2025, from $95,087,000 in the prior year.
- The acquired business's loss before income tax provision widened significantly to $73,356,000 for the nine months ended June 30, 2025, from $9,153,000 in the prior year.
- The acquired business shifted from generating $10,732,000 in cash from operating activities for the nine months ended June 30, 2024, to using $33,440,000 in operating activities for the same period in 2025.
- The acquired business's total liabilities increased to $1,569,938,000 as of June 30, 2025, from $1,488,899,000 as of September 30, 2024, with a notable increase in the current portion of long-term debt to $489,039,000 from $47,579,000.
- Prospect Medical Group (PMG), part of the acquired business, was out of compliance with its tangible net equity and working capital requirements as of June 30, 2025.
- PMH, the former parent of parts of the acquired business, was in default under certain MPT Term Loan covenants as of June 30, 2025, and its remaining assets were added to bankruptcy proceedings on July 7, 2025.
Risks
- The acquired business (PHP Holdings, LLC & Rhode Island Market) was not in compliance with Tangible Net Equity (TNE) and working capital requirements as of June 30, 2025, which could lead to regulatory scrutiny or operational limitations.
- California hospitals, including Alta Newport Hospital (part of the acquired business), are subject to seismic safety standards that require significant operational changes and capital outlays, with costs currently not estimable.
- The healthcare industry is highly regulated, and non-compliance with laws such as HIPAA, HITECH Act, and fraud/abuse statutes could result in significant fines, penalties, or exclusion from government healthcare programs.
- Payer and provider contracts are complex and subject to differing interpretations, which may lead to claims disputes and adjustments to reserves, impacting future operations.
- The pro forma financial information is for illustrative purposes only and may not be indicative of future operating results, as it does not account for potential synergies, operating efficiencies, tax savings, or cost savings.
Future Outlook
The filing provides pro forma financial information for Astrana Health, Inc. for the fiscal year ended December 31, 2025, reflecting the acquisition and related financing as if they had occurred on January 1, 2025. This pro forma statement projects a total revenue of $3,819,909,000 and net income attributable to Astrana Health, Inc. of $41,391,000, with basic and diluted earnings per share of $0.84. However, the company explicitly states that this information is for illustrative purposes only and is not indicative of future consolidated results of operations, nor does it account for potential synergies, operating efficiencies, tax savings, or cost savings.
Management Comments
- Management believes [pro forma adjustments] are reasonable under the circumstances.
- Management is of the opinion that the associated liabilities recognized in the accompanying condensed combined and consolidated financial statements are adequate to cover such claims.
- Management is not aware of any potential claims whose settlement, if any, would have a material adverse effect on the Company’s combined and consolidated financial position, results of operations or cash flows.
- The Company and its affiliates believe that they are in compliance with all applicable laws and regulations, and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing.
- Management is continuing to assess its options and the methods of financing the required retrofits.
Industry Context
StockSavvy.ai notes that this acquisition by Astrana Health, Inc. reflects a continuing trend of consolidation within the U.S. healthcare sector, particularly in managed care and hospital services. Companies are seeking to expand their geographic footprint, increase member populations, and achieve economies of scale to navigate complex regulatory environments and rising healthcare costs. The integration of a health plan (Prospect Health Plan) and an acute care hospital (Alta Newport Hospital) suggests a strategy to enhance vertical integration, potentially leading to better care coordination and cost management, a common objective among larger healthcare providers aiming to compete with diversified players like UnitedHealth Group (Optum) or CVS Health (Aetna). The challenges faced by the acquired business, such as non-compliance with TNE requirements and significant debt, highlight the financial pressures smaller or less integrated entities can experience, making them attractive targets for larger, better-capitalized acquirers.
Comparison to Industry Standards
- The acquisition of Prospect Health Plan and Alta Newport Hospital by Astrana Health, Inc. aligns with the broader industry trend of vertical integration seen in major healthcare players. For instance, UnitedHealth Group's Optum division has aggressively acquired physician groups and care delivery assets, aiming to control more aspects of the patient journey and improve cost efficiencies. Similarly, CVS Health's acquisition of Aetna aimed to integrate pharmacy benefits, health insurance, and retail clinics.
- The financing of $707.3 million via a delayed draw term loan credit facility is a standard approach for funding significant acquisitions in the healthcare sector, comparable to debt structures used by companies like HCA Healthcare for hospital expansions or Tenet Healthcare for strategic acquisitions.
- The acquired business's historical financial performance, including a net loss of $38.69 million and a significant decline in operating income for the nine months ended June 30, 2025, suggests it was underperforming relative to more robust, publicly traded healthcare providers. For example, well-managed regional health systems or managed care organizations typically aim for consistent profitability and positive operating cash flows.
- The non-compliance of Prospect Medical Group with Tangible Net Equity and working capital requirements indicates a financial solvency issue that is below industry best practices for regulated healthcare entities, which are typically required to maintain specific capital reserves to ensure claims payment ability. This situation is a red flag that Astrana will need to address post-acquisition, similar to how regulatory issues are managed in acquisitions involving financially distressed entities.
- The substantial debt burden of the acquired business, totaling over $1.2 billion prior to repayment, is indicative of a highly leveraged entity, which is not uncommon for private equity-backed healthcare assets but typically exceeds the leverage ratios of more financially stable public companies in the sector.
Legal Proceedings
- The acquired business is subject to a variety of claims and suits arising in the ordinary course of business, acquisitions, or other transactions. Management believes these will not have a material adverse impact, but acknowledges inherent uncertainties.
- PMH and certain wholly-owned subsidiaries (including PHSRI and PPGRI, part of the Rhode Island Market) filed for Chapter 11 bankruptcy reorganization on January 11, 2025.
- The remaining assets and entities of PHP Holdings, LLC not transferred to Astrana were added to the PMH bankruptcy proceedings on July 7, 2025.
Related Party Transactions
- Prior to the acquisition, PHP Holdings, LLC had extensive related party transactions with Prospect Medical Holdings, Inc. (PMH) and its subsidiaries, including risk pool sharing agreements, management service agreements, and hospital services agreements.
- Management fees earned from related parties by PHP Holdings, LLC for the nine months ended June 30, 2025, totaled $3,237,000.
- PHP Holdings, LLC incurred $6,561,000 in management fees to Coordinated Regional Care Group, Inc. (CRCG), a PMH subsidiary, for the nine months ended June 30, 2025.
- PHP incurred $144,133,000 in capitation expense to Alta Los Angeles Hospitals, Inc., Southern California Healthcare System, Inc., and Alta Newport, all PMH subsidiaries, for the nine months ended June 30, 2025.
- Balances included in "due from related parties" for PMH and subsidiaries were $21,110,000 as of June 30, 2025.
- The Foothill Note, an intercompany loan of $75,000,000 from PMG to FRMC Hospital Property, LLC (a PIH subsidiary), was fully repaid by April 30, 2025.
Stakeholder Impact
- Shareholders (Astrana): The acquisition is expected to be accretive to revenue and net income, potentially increasing shareholder value. However, the pro forma nature of the financials means actual results could differ.
- Shareholders (PMH/Acquired Business): The sale of key assets to Astrana and the repayment of significant debt for the acquired entities provide a resolution for a financially distressed part of PMH, while the remaining assets of PHPH are now part of PMH's bankruptcy proceedings.
- Employees (Acquired Business): The acquisition likely brings stability and new ownership, but may also lead to integration-related changes in roles or operations.
- Customers/Patients (Acquired Business): The acquisition by a larger entity like Astrana Health could lead to improved services, broader network access, or changes in care delivery models.
- Creditors (Acquired Business): The full repayment of over $1.2 billion in debt associated with the PhysicianCo Loan Agreement is a positive outcome for those creditors.
- Regulatory Authorities: The acquisition and subsequent financial reporting will be subject to ongoing scrutiny, particularly regarding the historical non-compliance issues of Prospect Medical Group and the seismic standards for Alta Newport.
Next Steps
- Astrana Health, Inc. will integrate the acquired entities (Prospect Health Plan, Alta Newport Hospital, and other assets) into its operations.
- Astrana Health, Inc. will need to address the historical non-compliance of Prospect Medical Group with Tangible Net Equity and working capital requirements.
- Management will continue to assess options and financing methods for required seismic retrofits at Alta Newport Hospital.
- The remaining assets and entities of PHP Holdings, LLC not transferred in the Astrana Sale will proceed through PMH's Chapter 11 bankruptcy proceedings.
- Astrana Health, Inc. will continue to finalize its valuation of the acquired assets and liabilities, with preliminary amounts subject to revision.
Key Dates
| Date | Description |
|---|---|
| 2013-03-25 | PHP Holdings, LLC (the Company or PHPH) was formed as a Delaware company. |
| 2017-07-01 | PMG entered into a risk sharing agreement with PHP and a third-party. |
| 2018-02-22 | PMH entered into an ABL Credit Agreement (the ABL Agreement). |
| 2019-08-23 | PMH closed a series of transactions with affiliates of Medical Properties Trust, Inc. (MPT), selling hospital buildings and entering into master lease agreements and a promissory note (TRS Note). |
| 2019-08-23 | MPT provided PMH with a $51,266,700 mortgage loan secured by Alta Newport (Foothill Mortgage Loan). |
| 2019-08-23 | Alta Newport entered into an agreement for PACE financing. |
| 2020-07-01 | Payments commenced for PACE financing. |
| 2020-11-30 | DMHC granted additional modification to the Knox-Keene license to include Commercial enrollees. |
| 2021-01-01 | PHP began accepting Commercial enrollees. |
| 2022-05-02 | An additional $50,000,000 loan was made by MPT to PMH and added to the Foothill Mortgage Loan. |
| 2022-10-12 | PHP Holdings, LLC converted from a Delaware corporation to a limited liability company. |
| 2023-03-30 | PMG became an indirect subsidiary of PHPH through a nominee physician shareholder arrangement. |
| 2023-03-31 | Rights and obligations of PMS and PHCA under MSAs were assigned to PIPH and then subcontracted back to PMS for tax consolidation purposes. |
| 2023-05-23 | The Company entered into the Third Amended and Restated Limited Liability Company Agreement, issuing Series A-1 Preferred Units to MPT. |
| 2023-05-23 | A Financing Agreement (PhysicianCo Loan Agreement) was executed, providing an Initial Term Loan of $375 million. |
| 2023-05-23 | PMH, the Company, and Prospect Healthcare Facilities Management, LLC entered into an Amended and Restated Master Restructuring Agreement (MRA) with MPT Picasso Investors TRS, LLC. |
| 2023-05-23 | PMG loaned $75,000,000 to PIH's subsidiary, FRMC Hospital Property, LLC (Foothill Note). |
| 2023-10-24 | An amendment to the PhysicianCo Loan Agreement was executed, making available delayed draw term loan commitments (2023 Bridge Loan Commitments). |
| 2023-11-17 | Prepayment of $48,311,000 made on the Foothill Note. |
| 2023-12-01 | Gateway Medicor Rancho Cucamonga, Inc. (GMRC) purchased assets of Abraham Chen, D.O.'s medical practice. |
| 2024-02-16 | PHSRI acquired a 10% membership interest in HealthAdvisors, LLC. |
| 2024-02-27 | Amendment No. 3 to PhysicianCo Loan Agreement extended the deadline for audited financial statements. |
| 2024-04-18 | California Department of Managed Health Care (DMHC) approved changes in indirect ownership of PHP. |
| 2024-04-30 | Amendment No. 4 to PhysicianCo Loan Agreement provided a limited waiver of certain events of default. |
| 2024-06-05 | Amendment No. 5 to PhysicianCo Loan Agreement facilitated an eCapital ABL Facility of PMH. |
| 2024-08-15 | An $8.5 million fee was earned and paid in kind to Lenders due to failure to satisfy a milestone under PhysicianCo Loan Agreement. |
| 2024-09-14 | Events of default occurred under the PhysicianCo Loan Agreement, leading to interest at the default rate. |
| 2024-09-30 | AMVI/Prospect (JV) was terminated and dissolved. |
| 2024-11-08 | PHPH, PMH, and affiliates entered into an Asset and Equity Purchase Agreement (Sale Agreement) with Astrana Health, Inc. |
| 2024-12-31 | Loan Parties exercised option to extend 2023 Bridge Loan maturity to June 30, 2025, paying an $8.5 million fee. |
| 2025-01-11 | PMH and certain wholly-owned subsidiaries (including PHSRI and PPGRI) filed for Chapter 11 bankruptcy reorganization. |
| 2025-02-10 | Lenders extended the maturity date of the 2023 Bridge Loan to March 31, 2026. |
| 2025-02-28 | Prepayment of $5,074,000 made on the Foothill Note. |
| 2025-03-12 | Astrana's annual report on Form 10-K for the fiscal year ended December 31, 2025, was filed with the SEC. |
| 2025-03-30 | Date of earliest event reported for this 8-K filing. |
| 2025-04-07 | Amendment No. 6 to the Financing Agreement was entered into, providing $34 million in incremental term loan commitments. |
| 2025-04-30 | Prepayment of $21,615,000 made on the Foothill Note, reducing principal balance to $0. |
| 2025-05-22 | PMH obtained a court order approving the sale of PHSRI and PPGRI assets to Astrana. |
| 2025-05-30 | The Company entered into an agreement to extend maturities of certain outstanding loans (2023 Bridge Loan, Amendment No. 6 Incremental Term Loan, Final Maturity Date under Financing Agreement) to June 1, 2026. |
| 2025-06-30 | End of the nine-month period for the acquired business's financial statements. |
| 2025-07-01 | The Astrana Sale closed, and all amounts outstanding under the PhysicianCo Loan Agreement were repaid in full. |
| 2025-07-07 | Remaining assets and entities of the Company not transferred in the Astrana Sale were added to the PMH bankruptcy proceedings. |
| 2025-09-30 | The date through which subsequent events were evaluated for the acquired business's financial statements. |
| 2026-03-31 | Maturity date of the 2023 Bridge Loan (as extended). |
| 2026-05-23 | Maturity date of the Initial Term Loan (PhysicianCo Term Loan) and MPT Term Loan. |
| 2026-06-01 | Extended maturity date for the 2023 Bridge Loan, Amendment No. 6 Incremental Term Loan, and Final Maturity Date under the Financing Agreement. |
| 2026-11-20 | Maturity date of The Phase I Convertible Note. |
| 2045-09-02 | Maturity date of PACE financing. |
Recommendation
buyThe acquisition significantly expands Astrana Health's operational scale and revenue base, as evidenced by the pro forma financials projecting over $3.8 billion in revenue and positive net income. The successful financing of the acquisition and the complete repayment of the acquired business's substantial debt immediately de-risks the acquired assets from their previous financial distress and default conditions. While the acquired business had historical losses and compliance issues, Astrana's ability to integrate and optimize these operations, coupled with the elimination of prior debt, presents a strong opportunity for long-term value creation and market share expansion in the consolidating healthcare sector.
Keywords
Healthcare Acquisition, SEC Filing, Astrana Health, Prospect Health Plan, Alta Newport Hospital, 8-K, Financial Statements, Pro Forma, Merger, Healthcare Services, Medical Group, Hospital Services, Capitation, Risk Management, Corporate Finance, Debt Repayment, Regulatory Compliance, Financial Reporting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.